Cargando…

Melatonin inhibits osteoclastogenesis via RANKL/OPG suppression mediated by Rev‐Erbα in osteoblasts

Diabetic osteoporosis is secondary osteoporosis and a serious complication of diabetes with a high incidence rate and poor prognosis. The specific mechanism of diabetic osteoporosis is unclear, and prevention and treatment options are limited. Recently, melatonin has been found to prevent and treat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tian, Yihao, Ming, Jian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279587/ https://www.ncbi.nlm.nih.gov/pubmed/35726597 http://dx.doi.org/10.1111/jcmm.17440

Ejemplares similares

Melatonin inhibits RANKL-induced osteoclastogenesis through the miR-882/Rev-erbα axis in Raw264.7 cells
por: Tian, Yihao, et al.
Publicado: (2021)

Propofol attenuates osteoclastogenesis by lowering RANKL/OPG ratio in mouse osteoblasts
por: Lee, Do-Won, et al.
Publicado: (2018)

BMP-induced Atoh8 attenuates osteoclastogenesis by suppressing Runx2 transcriptional activity and reducing the Rankl/Opg expression ratio in osteoblasts
por: Yahiro, Yuhei, et al.
Publicado: (2020)

(5R)-5-Hydroxytriptolide (LLDT-8) inhibits osteoclastogenesis via RANKL/RANK/OPG signaling pathway
por: Shen, Yi, et al.
Publicado: (2015)

Regulation of Circadian Behavior and Metabolism by Rev-erbα and Rev-erbβ
por: Cho, Han, et al.
Publicado: (2012)

Serum RANKL, osteoprotegerin (OPG), and RANKL/OPG ratio in nephrotic children
por: Wasilewska, Anna, et al.
Publicado: (2010)

A Jak1/2 inhibitor, baricitinib, inhibits osteoclastogenesis by suppressing RANKL expression in osteoblasts in vitro
por: Murakami, Kohei, et al.
Publicado: (2017)

Bu-Shen-Ning-Xin decoction suppresses osteoclastogenesis by modulating RANKL/OPG imbalance in the CD4(+) T lymphocytes of ovariectomized mice
por: Zhang, Jia-Li, et al.
Publicado: (2018)

The Nuclear Receptor and Clock Repressor Rev-erbα Suppresses Myogenesis
por: Chatterjee, Somik, et al.
Publicado: (2019)

REV-ERBα and REV-ERBβ function as key factors regulating Mammalian Circadian Output
por: Ikeda, Ryosuke, et al.
Publicado: (2019)

Inhibition of RANKL-Induced Osteoclastogenesis by Novel Mutant RANKL
por: Jang, Yuria, et al.
Publicado: (2021)

Distinct roles for REV-ERBα and REV-ERBβ in oxidative capacity and mitochondrial biogenesis in skeletal muscle
por: Amador, Ariadna, et al.
Publicado: (2018)

Mechanism of genistein regulating the differentiation of vascular smooth muscle cells into osteoblasts via the OPG/RANKL pathway
por: Shen, Cheng, et al.
Publicado: (2017)

Rev-erbα Negatively Regulates Osteoclast and Osteoblast Differentiation through p38 MAPK Signaling Pathway
por: Kim, Kabsun, et al.
Publicado: (2020)

Substance P Promotes the Proliferation, but Inhibits Differentiation and Mineralization of Osteoblasts from Rats with Spinal Cord Injury via RANKL/OPG System
por: Liu, Hai-Juan, et al.
Publicado: (2016)

Author Correction: The Nuclear Receptor and Clock Repressor Rev-erbα Suppresses Myogenesis
por: Chatterjee, Somik, et al.
Publicado: (2022)

Treatment of OPG-deficient mice with WP9QY, a RANKL-binding peptide, recovers alveolar bone loss by suppressing osteoclastogenesis and enhancing osteoblastogenesis
por: Ozaki, Yuki, et al.
Publicado: (2017)

Probiotic Propionibacterium freudenreichii MJ2 Enhances Osteoblast Differentiation and Mineralization by Increasing the OPG/RANKL Ratio
por: Yeom, Jiah, et al.
Publicado: (2021)

Targeting the RANKL/RANK/OPG Axis for Cancer Therapy
por: Ming, Jie, et al.
Publicado: (2020)

RANK/RANKL/OPG system in the intervertebral disc
por: Takegami, Norihiko, et al.
Publicado: (2017)

Madecassoside inhibits estrogen deficiency‐induced osteoporosis by suppressing RANKL‐induced osteoclastogenesis
por: Wang, Qingqing, et al.
Publicado: (2018)

Serum levels of RANKL and OPG, and the RANKL/OPG ratio in bisphosphonate-related osteonecrosis of the jaw: Are they useful biomarkers for the advanced stages of osteonecrosis?
por: Bagan, Leticia, et al.
Publicado: (2017)

Novel Function of Rev-erbα in Promoting Brown Adipogenesis
por: Nam, Deokhwa, et al.
Publicado: (2015)

Rev-erbα in the brain is essential for circadian food entrainment
por: Delezie, Julien, et al.
Publicado: (2016)

Targeting REV-ERBα for therapeutic purposes: promises and challenges
por: Wang, Shuai, et al.
Publicado: (2020)

Downregulation of REV-ERBα is associated with the progression of lung adenocarcinoma
por: Zhang, Hao, et al.
Publicado: (2022)

Cytochalasin Z11 inhibits RANKL-induced osteoclastogenesis via suppressing NFATc1 activation
por: Wang, Lu, et al.
Publicado: (2019)

Decreased expression of Rev-Erbα in the epileptic foci of temporal lobe epilepsy and activation of Rev-Erbα have anti-inflammatory and neuroprotective effects in the pilocarpine model
por: Yue, Jiong, et al.
Publicado: (2020)

Effects of TGF-β1 on OPG/RANKL Expression of Cementoblasts and Osteoblasts Are Similar without Stress but Different with Mechanical Compressive Stress
por: Yang, Xianrui, et al.
Publicado: (2015)

Calycosin Suppresses RANKL-Mediated Osteoclastogenesis through Inhibition of MAPKs and NF-κB
por: Quan, Gui-Hua, et al.
Publicado: (2015)

α-Linolenic Acid Inhibits RANKL-Induced Osteoclastogenesis In Vitro and Prevents Inflammation In Vivo
por: Deng, Yufeng, et al.
Publicado: (2023)

The Effect of RANKL/OPG Balance on Reducing Implant Complications
por: Kapasa, Elizabeth R., et al.
Publicado: (2017)

Substance P participates in periodontitis by upregulating HIF-1α and RANKL/OPG ratio
por: Yan, Kaixian, et al.
Publicado: (2020)

The Nuclear Receptor Rev-erbα Controls Circadian Thermogenic Plasticity
por: Gerhart-Hines, Zachary, et al.
Publicado: (2013)

REV-ERBα influences the stability and nuclear localization of the glucocorticoid receptor
por: Okabe, Takashi, et al.
Publicado: (2016)

REV-ERBα Regulates T(H)17 Cell Development and Autoimmunity
por: Amir, Mohammed, et al.
Publicado: (2018)

Age of donor alters the effect of cyclic hydrostatic pressure on production by human macrophages and osteoblasts of sRANKL, OPG and RANK
por: Evans, CE, et al.
Publicado: (2006)

Bisphosphonates Reduce Smoking-Induced Osteoporotic-Like Alterations by Regulating RANKL/OPG in an Osteoblast and Osteoclast Co-Culture Model
por: Zhu, Sheng, et al.
Publicado: (2020)

Suppression of Osteoclastogenesis by Melatonin: A Melatonin Receptor-Independent Action
por: Kim, Hyung Joon, et al.
Publicado: (2017)

Galangin suppresses RANKL‐induced osteoclastogenesis via inhibiting MAPK and NF‐κB signalling pathways
por: Li, Xiucheng, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_c8je7v2k9jdtf7n5prp7tfq8rl